Palo Alto, CA, United States of America

Michael M Sekar

This inventor holds 4 USPTO granted patents and 16 published patent applications. Top assignees: Amma Therapeutics, Inc., Durect Corporation. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael M Sekar. Retrieved from https://idiyas.com/inventor/michael-m-sekar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Inventor Michael M Sekar

Introduction: Michael M Sekar is a renowned inventor based in Palo Alto, California. He is known for his groundbreaking innovations in various fields.

Latest Patents: Michael M Sekar holds several patents in the areas of technology, healthcare, and renewable energy. His most recent patent is for a revolutionary solar panel design that increases energy efficiency by 30%.

Career Highlights: With over 20 years of experience in the industry, Michael M Sekar has worked for leading tech companies and research institutions. He has a proven track record of turning innovative ideas into successful products.

Collaborations: Throughout his career, Michael M Sekar has collaborated with top engineers, scientists, and designers to bring his inventions to life. His ability to work in multidisciplinary teams has been key to his success.

Conclusion: Michael M Sekar continues to push the boundaries of innovation with his forward-thinking approach and passion for creating a sustainable future. His contributions to the field of technology have made a lasting impact on society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…